Live Breaking News & Updates on Ophthalmol Vis

Stay updated with breaking news from Ophthalmol vis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HORNBILL: BI 764524 Meets Safety Endpoints in Diabetic Macular Ischemia

BI 764524 was well tolerated following intravitreal administration of single and multiple doses in the phase 1/2a trial, with signs pointing to early efficacy. ....

Quan Dong Nguyen , Stanford University Quan Dong Nguyen , Byers Eye Institute , Association For Research , Boehringer Ingelheim , Stanford University , Newswire News , Ophthalmol Vis ,